mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.004 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.006 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.006 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.007 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.008 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.008 |